Overview

Safety Study of Gleevec® in Children With Pulmonary Hypertension

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if the drug, Gleevec, is safe and effective in treating children with Pulmonary Hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University
Treatments:
Imatinib Mesylate